Normal Values for Ferritin

Rangos normales por grupo poblacional

• The normal serum ferritin values are 135 μg/L for men, 43 μg/L for women, and approximately 30 μg/L for children aged 6-24 months, according to the Centers for Disease Control and Prevention (CDC) 1
• The average serum ferritin value for adult men is 135 μg/L, as recommended by the CDC 1
• The average serum ferritin value for adult women is 43 μg/L, as recommended by the CDC 1
• The average serum ferritin value for children aged 6-24 months is approximately 30 μg/L, as recommended by the CDC 1

Interpretación clínica de los valores de ferritina

• A serum ferritin level <15 μg/L is highly specific for iron deficiency (specificity 0.99), as reported by the European Society of Gastroenterology 2
• Levels <30 μg/L generally indicate low body iron stores, as reported by the European Society of Gastroenterology 2
• Values <45 μg/L may justify gastrointestinal investigation, especially in the presence of chronic inflammatory processes (specificity 0.92), as reported by the European Society of Gastroenterology 2
• Values >150 μg/L rarely occur with absolute iron deficiency, even in the presence of inflammation, as reported by the European Society of Gastroenterology 2
• Iron deficiency without anemia is characterized by low ferritin levels but normal hemoglobin, as reported by the European Society of Gastroenterology 2

Consideraciones importantes

• Ferritin is an acute-phase protein; infections, inflammations, or diseases that cause tissue damage can elevate its concentration independently of iron status, as reported by the CDC 1
• This elevation can mask depleted iron stores, as reported by the CDC 1
• There is a direct relationship between serum ferritin concentration and the amount of iron stored in the body: 1 μg/L of serum ferritin equals approximately 10 mg of stored iron, as reported by the CDC 1
• Serum ferritin is an early indicator of iron store status and is the most specific indicator available of depleted iron stores, as reported by the CDC 1

Puntos clave para la práctica clínica

• Serum ferritin should be interpreted along with other iron parameters, such as transferrin saturation, and clinical context, as recommended by the American Gastroenterological Association 3
• In patients with inflammation, iron deficiency may be present with ferritin levels up to 50-100 μg/L, as recommended by the American Gastroenterological Association 3

Iron Status Markers

Introduction to Iron Metabolism

• Serum iron measures the amount of iron bound to transferrin in the bloodstream, representing iron that is currently in transit and available for immediate use in erythropoiesis 4
• Serum ferritin reflects storage iron that is contained within liver, spleen, and bone marrow reticuloendothelial cells, serving as a reliable indicator of total body iron stores 4, 5

Assessing Iron Availability

• Transferrin saturation (TSAT), which is calculated using serum iron, indicates the percentage of transferrin binding sites occupied by iron and reflects iron readily available for erythropoiesis 5

Complementary Testing for Iron Status

• Neither serum iron nor ferritin alone provides a complete picture of iron status - they should be interpreted together 4, 5
• The percentage of hypochromic red cells may help assess iron status when ferritin and TSAT results are discordant 4

Diagnosing Iron Deficiency Using Serum Iron and Ferritin

Introduction to Iron Deficiency Diagnosis

• The American Journal of Kidney Diseases recommends using both serum iron and ferritin to diagnose iron deficiency, as serum ferritin reflects iron storage levels and serum iron measures circulating iron 6, 7

Key Differences Between Serum Iron and Ferritin

• Serum iron is used to calculate Transferrin Saturation (TSAT) by the formula: (serum iron × 100) ÷ TIBC, which reflects iron readily available for erythropoiesis rather than total body stores 6, 7
• Serum iron shows diurnal variation, which may affect interpretation if not collected at consistent times 6, 7
• Serum iron reflects readily available iron but not total body iron stores 6, 7

Diagnostic Value in Iron Deficiency

• The National Kidney Foundation suggests that TSAT < 20% traditionally indicates iron deficiency, though this is not perfectly accurate 8, 7
• TSAT reflects iron readily available for erythropoiesis rather than total body stores 6, 7
• In chronic kidney disease patients, absolute iron deficiency is defined as ferritin < 100 ng/mL and TSAT < 20% 6, 7

Clinical Pitfalls and Caveats

• Ferritin is an acute-phase reactant that increases during inflammation, potentially masking iron deficiency 8, 7
• When inflammation is present, a sudden increase in ferritin with a drop in TSAT suggests inflammatory iron block rather than true iron sufficiency 8, 7
• Absolute iron deficiency is characterized by depleted iron stores (low ferritin) with impaired iron delivery (low TSAT) 6, 7
• Functional iron deficiency is characterized by normal or elevated ferritin but insufficient iron release to meet demands, resulting in low TSAT 6, 7
• Distinguishing between functional iron deficiency and inflammatory iron block is a common clinical challenge, as both can present with TSAT < 20% and ferritin 100-700 ng/mL 8, 7

Iron Deficiency Diagnosis and Management

Introduction to Iron Deficiency

• A transferrin saturation of 14% is below the critical threshold of 16%, which is a sensitive marker for iron deficiency, though it has relatively low specificity (40-50%) 9
• Low transferrin saturation reflects insufficient iron readily available for red blood cell production 10, 11
• The pattern of low serum iron combined with low transferrin saturation indicates that iron delivery to the bone marrow for hemoglobin synthesis is impaired 11

Diagnostic Criteria

• Ferritin <15 μg/L has 99% specificity for iron deficiency, but ferritin is an acute-phase reactant that rises during inflammation, infection, or tissue damage, potentially masking true iron deficiency 9, 10
• Serum ferritin level is essential for distinguishing between absolute iron deficiency, functional iron deficiency, and anemia of chronic disease 9

Interpretation Algorithm

• If ferritin <15 μg/L, absolute iron deficiency is confirmed, and investigation of the source of iron loss should be initiated 9
• If ferritin 15-30 μg/L, iron deficiency with low stores is likely, and iron supplementation should be considered 9
• If ferritin 30-100 μg/L with elevated CRP/ESR, a mixed picture of true iron deficiency and anemia of chronic disease is present, and addressing the underlying inflammatory condition is necessary 9
• If ferritin >100 μg/L with elevated CRP/ESR, anemia of chronic disease (inflammatory iron block) is present, and treating the underlying inflammatory condition is the primary intervention 9

Clinical Significance

• Iron deficiency without anemia can still cause symptoms like fatigue and reduced exercise tolerance 12, 13
• Reduced aerobic performance and exercise intolerance are common in individuals with iron deficiency 12, 13

Low Ferritin with Normal Iron Panel: Diagnostic Interpretation

Understanding the Clinical Significance

• A low ferritin level in the absence of other iron panel abnormalities indicates depleted iron stores, which warrants intervention even before anemia develops, according to the British Journal of Sports Medicine 14
• Low ferritin is the earliest and most specific marker of iron deficiency, reflecting depleted body iron stores before other parameters become abnormal, with ferritin <35 μg/L indicating deficiency 14
• Hemoglobin remains normal in Stage 1 iron deficiency, where iron stores are depleted but anemia is not yet present 14

Diagnostic Thresholds and Interpretation

• Ferritin <15 μg/L has 99% specificity for iron deficiency, making it the gold standard for detecting depleted stores, as stated by Hepatology 15
• Ferritin <35 μg/L defines iron deficiency in athletes and general populations, according to the British Journal of Sports Medicine 14

Clinical Consequences of Low Ferritin Alone

• Depleted iron stores cause significant symptoms, including fatigue and lethargy, even without anemia, as reported by the British Journal of Sports Medicine 14

Management Algorithm

• When ferritin <15 μg/L, absolute iron deficiency is confirmed, and oral iron supplementation should be initiated immediately, along with investigation for the source of iron loss, as recommended by the British Journal of Sports Medicine 14
• When ferritin is 15-35 μg/L, iron deficiency with low stores is likely, and a diet rich in iron, as well as consideration of oral iron supplementation, is recommended by the British Journal of Sports Medicine 14

High-Risk Populations Requiring Vigilance

• Menstruating females, vegetarians/vegans, athletes, and regular blood donors are at high risk for iron deficiency and require more frequent screening, with the British Journal of Sports Medicine recommending twice yearly screening for menstruating females and annual screening for males 14

Management of Low Ferritin with Normal Serum Iron

Diagnostic Thresholds

• Ferritin <15 μg/L has 99% specificity for absolute iron deficiency and confirms diagnosis definitively, according to the European Society of Gastrointestinal Endoscopy 16
• Ferritin 15-30 μg/L indicates low body iron stores and generally warrants treatment, as recommended by the European Society of Gastrointestinal Endoscopy 16
• Ferritin <45 μg/L provides optimal sensitivity-specificity balance (specificity 0.92) for clinical decision-making, as suggested by the European Society of Gastrointestinal Endoscopy 16

Critical Caveat: Rule Out Inflammation

• In inflammatory conditions (IBD, chronic kidney disease, heart failure), ferritin thresholds shift upward to <100 μg/L, as indicated by the European Crohn's and Colitis Organisation 17
• Calculate transferrin saturation (TSAT): values <16% indicate iron deficiency even with higher ferritin, according to the European Crohn's and Colitis Organisation 17

Long-Term Management

• For patients with recurrent low ferritin, screen every 6-12 months depending on risk factors, as recommended by the European Crohn's and Colitis Organisation 17

Iron Deficiency and Ferritin Thresholds

Clinical Thresholds for Iron Deficiency

• In patients with inflammation or chronic disease, the American Society of Clinical Oncology recommends a ferritin threshold of <30 ng/mL to indicate absolute iron deficiency 18
• The National Kidney Foundation suggests that ferritin <100 ng/mL is an appropriate threshold for iron deficiency in patients with cancer, chronic kidney disease, inflammatory bowel disease, or heart failure 18
• In chronic kidney disease patients not receiving erythropoiesis-stimulating agents, the Kidney Disease: Improving Global Outcomes guideline defines classic iron deficiency as ferritin <25 ng/mL for males or <11 ng/mL for females 19

Clinical Thresholds for Iron Overload

• In hemodialysis patients with low transferrin saturation (<25%), the Kidney Disease: Improving Global Outcomes guideline suggests that IV iron may still improve hemoglobin despite elevated ferritin levels of 500-1200 ng/mL 20

Complementary Testing Required

• The National Kidney Foundation recommends that transferrin saturation (TSAT) <20% is a traditional threshold indicating iron deficiency, particularly relevant in chronic kidney disease 21, 22

Iron Deficiency with Normal Serum Ferritin

Introduction to Iron Deficiency

• The most likely cause of iron deficiency with normal serum ferritin is anemia of chronic disease (inflammatory anemia), where iron is sequestered in the reticuloendothelial system and is not available for erythropoiesis, despite normal iron reserves, according to the European Crohn’s and Colitis Organisation 23

Diagnostic Criteria

• Diagnostic criteria for anemia of chronic disease include serum ferritin >100 μg/L and transferrin saturation <20% in the presence of inflammation, as recommended by the European Crohn’s and Colitis Organisation 23
• A combination of low serum iron and normal serum ferritin may represent a functional iron deficiency rather than an absolute deficiency, as stated by the European Crohn’s and Colitis Organisation 23

Mixed Iron Deficiency

• Mixed iron deficiency (absolute + functional) may occur when serum ferritin is between 30-100 μg/L in the context of inflammation, according to the European Crohn’s and Colitis Organisation 24, 23
• In this case, checking inflammatory markers such as CRP or ESR is essential to determine if ferritin is falsely elevated due to inflammation, as recommended by the European Crohn’s and Colitis Organisation 24

Diagnostic Algorithm

• The diagnostic algorithm for iron deficiency involves evaluating the presence of inflammation by measuring CRP and ESR, as recommended by the European Crohn’s and Colitis Organisation 24, 23
• If CRP/ESR are elevated, anemia of chronic disease is suspected; if CRP/ESR are normal, absolute iron deficiency is suspected, according to the European Crohn’s and Colitis Organisation 24, 23

Calculating Transferrin Saturation

• Transferrin saturation (TSAT) can be calculated using the formula: (serum iron × 100) ÷ total iron-binding capacity, as stated by the European Crohn’s and Colitis Organisation 24, 23
• A TSAT <16-20% confirms iron deficiency (absolute or functional), according to the European Crohn’s and Colitis Organisation 24, 23

Soluble Transferrin Receptor

• Soluble transferrin receptor (sTfR) is a useful test when ferritin and TSAT are discordant, as recommended by the European Crohn’s and Colitis Organisation 23
• An elevated sTfR confirms real iron deficiency, even in the presence of inflammation, according to the European Crohn’s and Colitis Organisation 23

Defining Serum Ferritin Thresholds for Iron Deficiency

Diagnostic Thresholds

• In patients with chronic kidney disease, absolute iron deficiency is defined as ferritin <100 ng/mL combined with transferrin saturation (TSAT) <20%, according to the National Kidney Foundation 25, 26
• The American Journal of Kidney Diseases recommends that for hemodialysis patients receiving erythropoiesis-stimulating agents (ESAs), target ferritin levels should exceed 200 ng/mL to optimize anemia correction and minimize ESA requirements 26
• Functional iron deficiency occurs when ferritin is 100-700 ng/mL but TSAT remains <20%, indicating adequate iron stores but insufficient iron release to support erythropoiesis, as stated by the American Journal of Kidney Diseases 25

Treatment Recommendations

• The Kidney International Supplements guidelines suggest that in CKD patients receiving ESAs, maintain ferritin >200 ng/mL and TSAT >20% to optimize hemoglobin response and reduce ESA requirements 26
• For hemodialysis patients with ferritin 500-1200 ng/mL but TSAT <25%, IV iron may still improve hemoglobin despite elevated ferritin, according to the Kidney International Supplements 26
• When distinguishing functional iron deficiency from inflammatory iron block is unclear, administer weekly IV iron (50-125 mg) for 8-10 doses; lack of erythropoietic response indicates inflammatory block, as recommended by the American Journal of Kidney Diseases 25

Safety Considerations

• The American Journal of Kidney Diseases warns that iron overload concerns primarily arise when ferritin chronically exceeds 1000 ng/mL, though tissue damage in dialysis patients differs from primary hemochromatosis 27
• Avoid IV iron supplementation when ferritin >500 ng/mL without clear evidence of functional iron deficiency (low TSAT with high ESA requirements), as advised by the Kidney International Supplements 26

Iron Deficiency Management

Diagnosis and Investigation

• For premenopausal women with iron deficiency, GI evaluation is conditional rather than mandatory, according to the American Gastroenterological Association 28
• Non-invasive testing for H. pylori and celiac disease serologies should be performed, as recommended by the American Gastroenterological Association 28
• If testing negative and patient is young with heavy menses, empiric iron supplementation alone is reasonable, as suggested by the American Gastroenterological Association 28
• Reserve bidirectional endoscopy for: positive H. pylori/celiac testing, GI symptoms, persistent iron deficiency despite adequate supplementation, or age >50 years, according to the American Gastroenterological Association 28
• New or worsening GI symptoms (abdominal pain, change in bowel habits, blood in stool) require urgent GI evaluation, as recommended by the American Gastroenterological Association 28
• Failure to respond to adequate oral iron therapy after 8-10 weeks requires urgent GI evaluation, according to the American Gastroenterological Association 28
• Age >50 years (higher risk of GI malignancy) requires urgent GI evaluation, as recommended by the American Gastroenterological Association 28

Treatment

• Initiate oral iron supplementation immediately with ferrous bisglycinate or ferrous sulfate 30-60 mg elemental iron daily, as recommended by the American Society for Clinical Nutrition 29
• Alternate-day dosing (60 mg every other day) may improve absorption and reduce gastrointestinal side effects compared to daily dosing, according to the American Society for Clinical Nutrition 29
• Take on empty stomach for optimal absorption, or with meals if gastrointestinal symptoms occur, as suggested by the American Society for Clinical Nutrition 29
• Expected side effects include constipation, nausea, or diarrhea, which can be minimized by taking with food or switching to alternate-day dosing, as reported by the American Society for Clinical Nutrition 29

Follow-Up and Monitoring

• Repeat CBC and ferritin in 8-10 weeks to assess response to treatment, as recommended by the American Society for Clinical Nutrition 29
• Target ferritin >100 ng/mL to restore iron stores and prevent recurrence, according to the American Society for Clinical Nutrition 29
• If no improvement, consider malabsorption, non-compliance, ongoing blood loss, or need for IV iron, as suggested by the American Society for Clinical Nutrition 29
• For patients with recurrent low ferritin (menstruating females, vegetarians, athletes), screen ferritin every 6-12 months, as recommended by the American Society for Clinical Nutrition 29
• Do not continue daily iron supplementation once ferritin normalizes, as this is potentially harmful, according to the American Society for Clinical Nutrition 29

Iron Deficiency Without Anemia in Premenopausal Women

Understanding the Laboratory Pattern

• The European Society of Gastroenterology recommends that a low transferrin saturation (less than 16-20%) is a sensitive marker for iron deficiency requiring treatment, as seen in this patient with a transferrin saturation of 7% 30
• Functional iron deficiency is characterized by normal ferritin levels (in this case, 114 ug/L) but low transferrin saturation, indicating insufficient iron available for red blood cell production despite adequate storage iron 30

Investigation Strategy for Premenopausal Women

• The American Gastroenterological Association suggests that GI investigation is not mandatory for premenopausal women with non-anemic iron deficiency unless specific red flags are present, such as GI symptoms or a strong family history of colorectal cancer 31, 32
• The European Society of Gastroenterology recommends screening for celiac disease with tissue transglutaminase antibodies (tTG) in patients with iron deficiency, as it is present in 3-5% of cases 30, 32
• The American College of Gastroenterology recommends testing for H. pylori non-invasively (stool antigen or urea breath test) in patients with iron deficiency 31
• Assessing menstrual blood loss history is crucial, as it is the most common cause of iron deficiency in premenopausal women 32, 33

Reserve Bidirectional Endoscopy

• The American Gastroenterological Association recommends reserving bidirectional endoscopy for patients with specific situations, such as age ≥50 years, GI symptoms, or a strong family history of colorectal cancer 31, 32
• Bidirectional endoscopy is also recommended for patients with positive celiac or H. pylori testing requiring confirmation, or for those who fail to respond to adequate oral iron therapy after 8-10 weeks 31, 32

Iron Supplementation Protocol

• The American Gastroenterological Association recommends starting oral iron supplementation immediately in patients with non-anemic iron deficiency, without waiting for investigation results 31

Critical Pitfalls to Avoid

• The European Society of Gastroenterology warns against assuming normal ferritin excludes iron deficiency, as transferrin saturation is the key parameter for assessing iron availability for erythropoiesis 30, 32
• The American College of Gastroenterology advises against performing extensive GI investigation in young, asymptomatic premenopausal women with heavy menses, as the yield is extremely low (0-6.5%) 30, 32
• The American Gastroenterological Association emphasizes the importance of not overlooking celiac disease, which is present in 3-5% of iron deficiency cases and can be easily missed without serologic screening 30, 32

Severe Iron Deficiency Diagnosis and Management

Diagnosis and Clinical Significance

• A ferritin level of 1 μg/L is far below the diagnostic threshold of <15 μg/L, which has 99% specificity for absolute iron deficiency, as stated by the European Crohn’s and Colitis Organisation 34, 35
• Patients can survive with severe iron deficiency because the body prioritizes iron delivery to essential organs and red blood cell production, even when stores are exhausted, according to the European Crohn’s and Colitis Organisation 34, 35

Expected Clinical Manifestations and Management

• As iron deficiency progresses, microcytic hypochromic anemia will eventually develop if left untreated, as reported by the European Crohn’s and Colitis Organisation 35
• With ferritin of 1 μg/L, absolute iron deficiency is definitively confirmed—no additional testing is needed for diagnosis, and the European Crohn’s and Colitis Organisation recommends checking complete blood count to assess for anemia 35
• Calculate transferrin saturation: expect <16%, confirming impaired iron delivery to bone marrow, as stated by the European Crohn’s and Colitis Organisation 34, 35

Special Considerations

• The presence of conditions impairing oral iron absorption, such as celiac disease or inflammatory bowel disease, may require intravenous iron supplementation, as noted by the European Crohn’s and Colitis Organisation 34, 35

Management of Iron Deficiency Without Anemia

Diagnosis and Treatment

• The British Society of Gastroenterology recommends starting oral iron supplementation immediately with ferrous sulfate 65 mg elemental iron daily (or alternate-day dosing) and screening for celiac disease with tissue transglutaminase antibodies in patients with iron deficiency without anemia 36, 37
• A ferritin level of 37 μg/L is considered above the absolute deficiency threshold of <15 μg/L but below the optimal cutoff of 45 μg/L, indicating depleted iron stores 36
• The calculated transferrin saturation (TSAT) of 21% combined with ferritin 37 μg/L confirms iron deficiency, as values <30 μg/L generally indicate low body iron stores 36, 38
• Elevated TIBC reflects the body's attempt to capture more circulating iron when stores are low, with a TIBC of 430 mg/dL indicating iron deficiency 36

Screening and Investigation

• The American Gastroenterological Association recommends conditional rather than mandatory GI evaluation for premenopausal women with iron deficiency, reserving bidirectional endoscopy for patients with GI symptoms, positive celiac or H. pylori testing, or failure to respond to adequate oral iron therapy 37
• Celiac disease is present in 3-5% of iron deficiency cases and can cause treatment failure if not identified, making serologic screening with tissue transglutaminase antibodies essential 37

Monitoring and Follow-Up

• The expected response to iron supplementation is a hemoglobin rise ≥10 g/L within 2 weeks, and repeat CBC and ferritin should be assessed at 8-10 weeks to evaluate response to treatment 37, 39

Interpreting Ferritin Levels

Introduction to Ferritin Interpretation

• A ferritin level of 55 μg/L falls in the borderline zone where iron stores are likely adequate in most adults, but this value does not definitively exclude iron deficiency, particularly in the presence of inflammation or chronic disease 40, 41

Diagnostic Considerations

• A ferritin threshold of <45 μg/L has 85% sensitivity and 92% specificity for iron deficiency, meaning a level of 55 μg/L makes true iron deficiency less likely but not impossible 40, 41
• Ferritin is an acute-phase reactant that rises during inflammation, infection, or tissue damage, potentially masking underlying iron deficiency 42

Assessment of Iron Availability

• Ferritin alone provides an incomplete picture—you must calculate transferrin saturation (TSAT) to assess iron availability for red blood cell production 42
• If TSAT <20%, this indicates functional iron deficiency despite the ferritin of 55 μg/L, meaning insufficient iron is available for erythropoiesis 42

Guidance on Iron Supplementation

• Initiate iron supplementation if TSAT <20% (regardless of ferritin level), or if the patient has symptoms of iron deficiency, belongs to high-risk groups, or has a chronic inflammatory condition with TSAT <20% 42

Diagnostic Use of Ferritin and Adjustments in Inflammatory States

Diagnostic Thresholds

Influence of Inflammation on Ferritin Interpretation

Management of Low Iron, Low Ferritin with Normal TIBC

1. Interpretation of the Atypical Laboratory Pattern

• The combination of low serum iron, low ferritin, and normal TIBC suggests either very early absolute iron deficiency (before the compensatory rise in TIBC) or co‑existent inflammation that suppresses TIBC elevation; immediate measurement of inflammatory markers (CRP, ESR) is required to differentiate the two possibilities. 44, 45
• Low ferritin < 15–30 µg/L is a hallmark of iron deficiency. 44
• Transferrin saturation (TSAT) < 16–20 % confirms iron deficiency regardless of ferritin level. 46, 44
• Inflammatory states (e.g., chronic infection, malignancy) can suppress the expected TIBC rise even when true iron deficiency is present. 46, 45
• Conditions such as inflammatory bowel disease, chronic kidney disease, and occult malignancy are common causes of this mixed laboratory picture. 45

2. Immediate Diagnostic Algorithm

2.1 Check Inflammatory Markers

• Measure CRP and ESR without delay. Elevated values point toward anemia of chronic disease co‑existing with iron deficiency; normal values favor early absolute iron deficiency. 44, 45

2.2 Calculate and Interpret Transferrin Saturation

• TSAT = (Serum iron × 100) ÷ TIBC. A TSAT < 16 % confirms iron deficiency irrespective of ferritin; a TSAT < 20 % in the presence of inflammation indicates functional iron deficiency. 46, 45

2.3 Assess Ferritin in Context

• Ferritin < 15 µg/L has ≈ 99 % specificity for absolute iron deficiency. 44
• Ferritin 15–30 µg/L denotes depleted iron stores. 44
• Ferritin 30–100 µg/L together with elevated CRP/ESR signifies mixed iron deficiency (absolute + functional). 45

3. Evaluation of Iron Loss Sources

3.1 Adults (men and non‑menstruating women)

• Screen for celiac disease using tissue transglutaminase antibodies; celiac disease accounts for 3–5 % of iron‑deficiency cases. 44
• Perform non‑invasive testing for Helicobacter pylori. 44

3.2 Premenopausal women

• In addition to celiac and H. pylori screening, reserve bidirectional endoscopy for women ≥ 50 years, those with gastrointestinal symptoms, positive celiac/H. pylori tests, or lack of response to oral iron after 8–10 weeks. 44

4. Treatment Protocol

• Initiate oral iron therapy immediately; do not await completion of diagnostic work‑up. 44
• Expected hematologic response: hemoglobin should increase by ≥ 10 g/L within 2 weeks of starting therapy. 44

5. Follow‑Up and Monitoring

• Repeat complete blood count and ferritin at 8–10 weeks to assess response. 44
• Aim for ferritin > 100 ng/mL to fully replenish iron stores and prevent recurrence. 44
• For high‑risk groups (e.g., menstruating females, vegetarians, athletes), schedule ferritin screening every 6–12 months. 44

6. Critical Pitfalls

• Normal TIBC does not exclude iron deficiency; it must be interpreted alongside ferritin, serum iron, and inflammatory markers. 44, 45
• A normal TIBC with low iron and low ferritin may mask underlying chronic disease or malignancy; checking CRP/ESR helps uncover such hidden pathology. 45, 44, 45
• Celiac disease is present in 3–5 % of iron‑deficiency cases and should be screened for with tissue transglutaminase antibodies to avoid treatment failure. 44

Management of Iron Deficiency Without Anemia

Initial Assessment and Diagnosis

Immediate Treatment Recommendations

Concurrent Investigation of Underlying Causes

• Age ≥ 50 years (higher malignancy risk)
• Presence of gastrointestinal symptoms (abdominal pain, altered bowel habits, visible blood)
• Positive celiac or H. pylori testing that requires confirmation
• Lack of response to adequate oral iron after 8‑10 weeks
• Strong family history of colorectal cancer

Indications for Intravenous Iron Therapy

Pitfalls to Avoid

Guideline Recommendations for Immediate Management and Investigation of Severe Absolute Iron Deficiency

Immediate Oral Iron Therapy

• Patients with severe absolute iron deficiency (ferritin ≈ 11 ng/mL, transferrin saturation ≈ 12 %) should start oral iron supplementation without delay to correct the deficit and improve symptoms. 50

Mandatory Gastro‑Intestinal Investigation in High‑Risk Adults

• In adult men and post‑menopausal women, urgent bidirectional endoscopy (upper‑GI gastroscopy + colonoscopy) is required because iron deficiency may be the sole manifestation of gastrointestinal malignancy. 50

Indications for Switching to Intravenous Iron

*Dose recommendation is derived from the same guideline source.

*Patients meeting any of the above criteria should be transitioned to intravenous ferric carboxymaltose to achieve faster repletion and overcome absorption or loss barriers. 50

Management of Persistent Low Ferritin After Gastrointestinal Bleeding

Timeline of Iron Store Recovery

• Iron stores require 3–6 months to replenish after bleeding stops, provided the patient receives adequate iron supplementation. 51
• After hemoglobin normalizes, iron supplementation must be continued for an additional 3 months to fully restore ferritin levels. 51
• During weeks 2–8 post‑bleed, hemoglobin typically normalizes while ferritin remains low because absorbed iron is preferentially used for red‑cell production. 51
• Between months 3–6, excess absorbed iron begins to refill storage compartments, necessitating ongoing supplementation throughout this period. 51

Common Causes of Persistent Low Ferritin

• The most frequent reason ferritin remains low 5 months after a melena episode is lack of, or poor adherence to, oral iron therapy. 51
• Ferritin levels will not rise to >100 ng/mL unless oral iron is continued for 3 months after hemoglobin has normalized. 51
• Failure of ferritin to increase despite adequate oral iron (≈65 mg elemental iron daily for 8–10 weeks) should prompt evaluation for ongoing occult gastrointestinal bleeding. 51
• In patients ≥ 50 years or those with alarm symptoms (abdominal pain, weight loss, altered bowel habits), bidirectional endoscopy is mandatory to exclude gastrointestinal malignancy. 51
• Celiac disease accounts for 3–5 % of iron‑deficiency cases; screening with tissue transglutaminase IgA antibodies is recommended because untreated celiac disease can prevent ferritin recovery. 51
• Helicobacter pylori infection impairs iron absorption and should be screened with a non‑invasive stool antigen or urea‑breath test. 51

Diagnostic Evaluation

• A transferrin saturation < 16–20 % confirms iron deficiency and indicates insufficient iron for erythropoiesis. (Note: this threshold is widely accepted in iron‑deficiency guidelines.)
• Ferritin < 15 µg/L has 99 % specificity for absolute iron deficiency; values 15–30 µg/L denote depleted stores that require treatment. 51
• Order complete blood count to identify microcytic anemia (low MCV, low MCH) when iron deficiency progresses beyond storage depletion. 51
• Perform tTG‑IgA testing for celiac disease and non‑invasive testing for H. pylori as part of the initial work‑up. 51
• Reserve upper‑ and lower‑GI endoscopy for patients ≥ 50 years, those with gastrointestinal symptoms, positive celiac or H. pylori tests needing confirmation, lack of response to oral iron after 8–10 weeks, or a strong family history of colorectal cancer. 51

Oral Iron Supplementation Strategy

• Initiate oral ferrous sulfate delivering ≈ 65 mg elemental iron daily (or 60–65 mg every other day); alternate‑day dosing improves absorption by 30–50 % and reduces gastrointestinal side effects. 51
• Expected therapeutic response: hemoglobin should rise by ≥ 10 g/L within 2 weeks; absence of this rise suggests malabsorption, non‑compliance, or ongoing blood loss. 51
• Continue oral iron for 3 months after hemoglobin normalization to achieve a target ferritin > 100 ng/mL and prevent rapid recurrence. 51

Intravenous Iron Indications and Efficacy

• Switch to intravenous ferric carboxymaltose (15 mg/kg, max 1000 mg per dose) when any of the following apply: oral intolerance, confirmed malabsorption (e.g., celiac disease, inflammatory bowel disease, post‑bariatric anatomy), ongoing blood loss exceeding oral replacement capacity, chronic inflammatory conditions (CKD, heart failure, cancer), or pregnancy in the second/third trimester. 51
• IV iron produces reticulocytosis within 3–5 days and yields an average hemoglobin increase of ≈ 8 g/L over 8 days, demonstrating superior efficacy in the indicated populations. 51

Monitoring and Follow‑Up

• Re‑check CBC and ferritin at 8–10 weeks after initiating oral iron to assess therapeutic response. 51
• Persistent failure of ferritin to rise despite adequate supplementation signals ongoing blood loss or malabsorption and warrants urgent gastrointestinal evaluation. 51
• For individuals at risk of recurrent iron depletion (e.g., menstruating females, vegetarians, endurance athletes), schedule ferritin screening every 6–12 months to detect early depletion before anemia develops. 51

Critical Pitfalls to Avoid

• Do not assume ferritin will normalize spontaneously after bleeding stops; dietary iron alone is insufficient to replenish stores within a clinically acceptable timeframe. 51
• Do not discontinue iron therapy once hemoglobin normalizes; an additional 3 months of supplementation is required for ferritin to reach > 100 ng/mL. 51
• Do not overlook celiac disease screening, given its 3–5 % prevalence among iron‑deficiency cases; missing this diagnosis leads to treatment failure. 51
• Do not delay endoscopic evaluation in high‑risk patients (age ≥ 50, alarm symptoms, treatment failure), as gastrointestinal malignancy can present solely with iron deficiency. 51

Diagnostic Criteria and Screening for Severe Iron Deficiency Anemia in Premenopausal Women

Diagnostic Laboratory Thresholds

• Ferritin concentrations below 15 µg/L provide ≈ 99 % specificity for absolute iron deficiency, making this cutoff a reliable diagnostic marker. 52
• Transferrin‑saturation values under 16 % (e.g., 4 %) indicate severely impaired iron delivery to the bone marrow and confirm iron‑deficiency physiology. 53
• Combined low serum iron (≈ 18 µg/dL) and reduced mean corpuscular volume (≈ 70 fL) characterize a microcytic, hypochromic anemia driven by iron‑restricted erythropoiesis. 52
• The World Health Organization defines moderate anemia in women as hemoglobin < 12 g/dL; values around 9–10 g/dL meet this criterion. [53][54]

Screening for Underlying Causes

• Tissue transglutaminase IgA testing for celiac disease should be performed because celiac disease accounts for 3–5 % of iron‑deficiency cases and is a frequent source of treatment failure when missed. 52
• Non‑invasive Helicobacter pylori testing (stool antigen or urea‑breath test) is recommended, as the organism can impair intestinal iron absorption. 52

Indications for Endoscopic Evaluation

• Upper and lower gastrointestinal endoscopy is indicated when patients present with gastrointestinal symptoms such as abdominal pain, altered bowel habits, or visible gastrointestinal bleeding. 52
• A strong family history of colorectal cancer also warrants endoscopic investigation to exclude occult malignancy. 54

Indications for Intravenous Iron Therapy

• Confirmed malabsorption syndromes—including celiac disease, inflammatory bowel disease, or post‑bariatric surgical anatomy—justify switching from oral to intravenous iron formulations. 55

Anemia of Chronic Disease: Evidence‑Based Key Points

Diagnostic Evaluation

• Complete blood count (CBC) with hemoglobin, mean corpuscular volume (MCV), and reticulocyte count is essential to assess anemia severity and red‑cell indices in patients with suspected anemia of chronic disease. 56

Red‑Cell Indices

• MCV is typically normal (normocytic) in anemia of chronic disease, but may become low (microcytic) when true iron deficiency co‑exists. 56

Ferritin Interpretation in Inflammatory Bowel Disease

• In active inflammatory bowel disease, a ferritin level as high as 100 µg/L can still signify iron deficiency because inflammation raises ferritin independently of iron stores. 56

Treatment Considerations for Inflammatory Bowel Disease

Managing the Underlying Inflammatory Process

• Failure to identify and treat the underlying chronic inflammatory disease (e.g., uncontrolled IBD, occult malignancy) results in ineffective anemia management and persistent treatment failure. 56

Management of Low Ferritin with Normal Hemoglobin

Diagnostic Criteria

• In individuals with normal hemoglobin, a serum ferritin < 15 µg/L has ≈ 99 % specificity for absolute iron deficiency and can be used to confirm the diagnosis definitively. 57
• A ferritin level of 15–30 µg/L indicates depleted body iron stores and warrants therapeutic iron replacement, even when hemoglobin remains within the normal range. 57

Oral Iron Formulations

• When ferrous sulfate is not tolerated, alternative oral iron preparations—such as ferrous bisglycinate (30–60 mg elemental iron daily) or ferrous gluconate/fumarate at equivalent elemental doses—are effective options for repleting iron stores. 57

Treatment Duration and Monitoring

• After hemoglobin normalizes, oral iron should be continued for an additional ≈ 3 months to raise ferritin above 100 µg/L and fully restore iron reserves, thereby preventing recurrence of deficiency‑related symptoms. 57

Anemia of Chronic Disease with Functional Iron Deficiency – Diagnostic Criteria and Genetic Mimics

Laboratory Pattern and Pathophysiology

• The triad of low serum iron, elevated ferritin, and low total iron‑binding capacity (TIBC) identifies anemia of chronic disease (inflammatory anemia) with functional iron deficiency, reflecting hepcidin‑mediated sequestration of iron in storage sites despite adequate total body iron stores. 58
• Elevated ferritin in this context indicates both iron storage in reticulo‑endothelial macrophages and an acute‑phase inflammatory response. 58
• When ferritin exceeds 100 ng/mL together with low TIBC and low serum iron, absolute iron deficiency can be excluded; the pattern instead signifies inflammation‑driven iron sequestration. 58

Rare Inherited Disorders That Mimic the Pattern

• Ferroportin disease (hereditary hemochromatosis type 4A) is caused by loss‑of‑function mutations in the ferroportin gene, leading to iron retention within macrophages, elevated ferritin, low‑to‑normal transferrin saturation, and poor tolerance to phlebotomy. 58
• Aceruloplasminemia is characterized by absent or markedly reduced ceruloplasmin, low serum copper and iron, markedly high ferritin, and hepatic iron overload; clinical manifestations include diabetes, retinal degeneration, and neurodegeneration presenting in the fourth to fifth decade of life. 58